Genomic Technologies, Government Initiatives, and Heightened Public Awareness Propel the Global Market for Personalized Medicine

A new study by Industry Experts, Inc., on "Personalized Medicine" has been published. Global Personalized Medicine market is estimated at US$531.7 billion in 2024 and projected to post a CAGR of 8.5% between 2024 and 2030 to reach US$869.9 billion by 2030.

The global market for personalized medicine is driven by several significant factors, such as advancements in genomic technologies, increased public awareness, and supportive government initiatives for personalized healthcare. Innovations in technologies like Next-Generation Sequencing (NGS), artificial intelligence (AI), machine learning (ML), liquid biopsy, and nanotechnology are revolutionizing personalized medicine by enabling more accurate and effective therapies. Additionally, an increase in clinical trials, innovations in pharmacogenomics, and the expansion of genetic databases are contributing to the market's growth. As healthcare continues to move toward a more individualized approach, the personalized medicine market is poised for sustained growth, driven by a blend of scientific, technological, and economic factors.

The personalized nutrition and wellness segment dominates the personalized medicine market with an estimated share of 45.9% in 2024, driven by rising consumer interest in customized health solutions and supportive regulatory frameworks. This segment emphasizes the development of personalized dietary regimens tailored to individual genetic profiles and lifestyle choices, targeting chronic illnesses such as obesity, diabetes, and heart disease. The growth is further enhanced by the increase in over-the-counter (OTC) sales and the incorporation of digital health technologies.

The global market for Personalized Medicine is analyzed in this report on a global basis covering all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, United Kingdom, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World.

The study analyzes the global market for Personalized Medicine based on the Product – Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics, and Personalized Nutrition & Wellness; Technology – Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics, and Other Technologies (Including Metabolomics, Pharmacodynamics, Pharmacokinetics, AI, ML, Liquid Biopsy, Nanotechnology, and others); Application – Oncology, Antiviral (Infectious Diseases), Immunology and Autoimmune Diseases, Neurology, Cardiovascular Diseases, Psychiatry, and Other Applications (Including Diabetes, Genetic Disorders, Coagulation and Blood Transfusion Safety, Respiratory Diseases, and others); and End-user – Hospitals, Diagnostic Centers, Research and Academic Institutes, and Other End-Users (Including Contract Research Organizations, Pharmaceutical and Biotech Companies, and others).

About Industry Experts, Inc.
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

Comments

Popular posts from this blog

Demand for Europium to Reach US$373.3 million by 2030 Fostered by Phosphors and Consumer Electronic Applications

Copper Demand to Reach US$368.8 B by 2030 Propelled by the Wide Range of Applications of the Metal Across Sectors

Oil & Gas Fuels Demand for Duplex Stainless Steel and Global Market to Reach $6 billion by 2030